Holt Capital Partners’s GSK GSK Stock Holding History

Holt Capital Partners’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-104	Closed	-$6K	–	242
2014 Q4	$6K	Buy	+104	New	+$5.82K	﹤0.01%	239

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Holt Capital Partners's GSK Position: Q1 2015 in Review

Holt Capital Partners sold out of GSK (GSK) in Q1 2015, closing a stake of 104 shares — an estimated $6K sold.

Holt Capital Partners first reported a position in GSK in Q4 2014 and held it in 1 quarter. The position peaked at $6K in Q4 2014. 740 funds tracked by Wall St. Rank hold GSK as of Q1 2015.

Holt Capital Partners reported no remaining GSK position as of Q1 2015 after selling out during the quarter.
Holt Capital Partners sold 104 GSK shares in Q1 2015, an estimated $6K.
Holt Capital Partners first reported a position in GSK in Q4 2014 and held it in 1 quarter.
Holt Capital Partners's GSK position peaked at $6K in Q4 2014.
740 funds tracked by Wall St. Rank held GSK as of Q1 2015.

Based on Holt Capital Partners's 13F filing for Q1 2015, filed 15 May 2015.